Crystalline Management’s Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 WRAC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-37,500
Closed -$1.88K 154
2023
Q1
$1.88K Hold
37,500
﹤0.01% 100
2022
Q4
$1.69K Buy
+37,500
New +$1.52K ﹤0.01% 130

Other funds holding WRAC.WS

Crystalline Management's WRAC.WS Position: Q2 2023 in Review

Crystalline Management sold out of Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 (WRAC.WS) in Q2 2023, closing a stake of 37,500 shares — an estimated $1.88K sold.

Crystalline Management first reported a position in WRAC.WS in Q4 2022 and held it in 2 quarters. The position peaked at $1.88K in Q1 2023. 8 funds tracked by Wall St. Rank hold WRAC.WS as of Q2 2023.

  • Crystalline Management reported no remaining Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 position as of Q2 2023 after selling out during the quarter.
  • Crystalline Management sold 37,500 Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 shares in Q2 2023, an estimated $1.88K.
  • Crystalline Management first reported a position in Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 in Q4 2022 and held it in 2 quarters.
  • Crystalline Management's Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 position peaked at $1.88K in Q1 2023.
  • 8 funds tracked by Wall St. Rank held Williams Rowland Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 as of Q2 2023.

Based on Crystalline Management's 13F filing for Q2 2023, filed 9 Aug 2023.